Jan Olof Svensson - Concepedia

Author

Jan Olof Svensson

Also Known As

J O Svensson, J Svensson, J. -O. SVENSSON, J. -O. Svensson, J. O. Svensson, J. SVENSSON, J. Svensson, J.- O. Svensson, J.-O. Svensson, J.O Svensson

Publications

Citations

H-Index

144

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet AstraZeneca (Sweden)Integrated Cardio Metabolic Centre Sundsvall Municipality

About

Jan Olof Svensson is an author at Karolinska University Hospital specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	4.4K
2	Health Sciences	6	6	274
3	Natural Sciences	5	5	3.3K
4	Public Health	4	4	165
5	Engineering	2	2	152

Jan Olof Svensson

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Mats Hámberg, Jan Olof Svensson, B Samuelsson Proceedings of the National Academy of Sciences Bioorganic ChemistryNew GroupSecondary MetaboliteChemical BiologyOxidative Stress	1975	3K
Plasma Testosterone, Aggressive Behavior, and Personality Dimensions in Young Male Delinquents Åke Mattsson, Daisy Schalling, Dan Olweus, Journal of the American Academy of Child Psychiatry Behavioral SciencesPersonality PsychologySexual OffendingPsychiatryJuvenile Delinquency	1980	146
Model for the Reduced Schiff Base Intermediate between Amino Acids and Pyridoxal: Copper(II) Complexes of <i>N</i>-(2-Hydroxybenzyl)amino Acids with Nonpolar Side Chains and the Crystal Structures of [Cu(<i>N</i>-(2-hydroxybenzyl)-<scp>d</scp>,<scp>l</scp>-alanine)(phen)]·H<sub>2</sub>O and [Cu(<i>N</i>-(2-hydroxybenzyl)-<scp>d</scp>,<scp>l</scp>-alanine)(imidazole)] Lip Lin Koh, John O. Ranford, Ward T. Robinson, Inorganic Chemistry Inorganic ChemistryEngineeringAmino AcidsBiochemistryNatural Sciences	1996	137
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans Jackson Mukonzo, Daniel Röshammar, Paul Waako, British Journal of Clinical Pharmacology	2009	137
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers* Per Hartvig, Johann Valtysson, Karl‐Johan Lindner, Clinical Pharmacology & Therapeutics NeuropsychologyPsychopharmacologyBrain ConcentrationsNeurophysiological BiomarkersPharmacotherapy	1995	117
Prostaglandin D2 as a potential antithrombotic agent Edward E. Nishizawa, William L. Miller, Robert R. Gorman, Prostaglandins InflammationThrombosisThrombopoiesisBlood PlateletMedicine	1975	109
A Randomized Trial of Adjuvant Combination Chemotherapy With Or Without Prednisone in Premenopausal Breast Cancer Patients With Metastases in One to Three Axillary Lymph Nodes Aron Goldhirsch, J. Stjemsward, Wolfgang Hartmann, Cancer Research Low-dose Continuous PrednisoneBreast OncologyMedicineMetronomic TherapyPharmacology	1985	98
Social and Sexual Adjustment of Men Operated for Hypospadias During Childhood: a Controlled Study Roland Berg, Jan Olof Svensson, Gaby Åström The Journal of Urology	1981	96
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Kari Laine, Gunnel Tybring, Sebastian Härtter, PubMed	2001	89
HYPOSPADIAS IS RELATED TO BIRTH WEIGHT IN DISCORDANT MONOZYGOTIC TWINS Louise Fredell, Paul Lichtenstein, Nancy L. Pedersen, The Journal of Urology	1998	85

Page 1